Skip to main content
Premium Trial:

Request an Annual Quote

Neogen Acquires Brazilian Animal Genomics Firm Deoxi

NEW YORK (GenomeWeb) – Food and animal safety firm Neogen announced today that it has acquired Brazilian animal genomics lab Deoxi Biotecnologia. 

Specific terms of the acquisition were not disclosed.

According to Neogen, the transaction is expected to accelerate adoption of its GeneSeek livestock genomic testing solutions in Brazil, which has an estimated 200 million cattle.

"Deoxi has excellent facilities and an excellent reputation with its customers [including] research institutions, universities, and animal breeding companies," Neogen Chairman and CEO James Herbert said in a statement. "Deoxi's management and staff will remain with the company and will continue their work to help Neogen grow the Brazilian genomics business."

Herbert added that samples from Neogen's Brazilian customers will now be proceeded at Deoxi's lab in that country, rather than being sent to Neogen's lab in Nebraska.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.